Treatment with Akero Therapeutics’ investigational efruxifermin led to reversals of compensated cirrhosis, or irreversible scarring in a still-functioning liver, among adults with metabolic dysfunction-associated…
Fatty liver disease
FATTY LIVER DISEASE
NewsRezdiffra reduces scarring in MASH with compensated cirrhosis: Trial
Long-term treatment with Rezdiffra (resmetirom) reduces liver scarring for most people with compensated cirrhosis, or irreversible scarring in a still-functioning liver, due to metabolic…
FATTY LIVER DISEASE
ColumnsI didn’t pay attention to my health until it took a turn for the worse
Groundhog Day is probably my favorite holiday. It’s pretty noncontroversial, really. Unless you really hate winter, you probably don’t have any problems with Punxsutawney Phil…
FATTY LIVER DISEASE
NewsAlgorithm spots people with MASLD, MASH using health records
Researchers have developed an algorithm to identify people with metabolic dysfunction-associated steatotic liver disease (MASLD), a type of fatty liver disease, based on information…
FATTY LIVER DISEASE
NewsPhase 2 trial of DD01 in treating MASH completes enrollment
D&D Pharmatech has finished enrolling a Phase 2 clinical trial of its experimental therapy DD01 in overweight or obese adults with metabolic dysfunction-associated steatohepatitis…
FATTY LIVER DISEASE
NewsTraffic pollution may increase risk of fatty liver disease: Mouse study
Long-term exposure to air pollution from traffic, even at relatively low concentrations, may increase the risk of fatty liver disease, according to a new…
HEPATITIS
NewsVirtual clinic for liver diseases opens to US patients
A virtual clinic for liver diseases, including hepatitis, has begun treating patients. The LiverRight Hepatology Clinic offers same-week video visits to adults who…
FATTY LIVER DISEASE
NewsWeight loss surgery may protect liver with MASH-related cirrhosis
Weight loss surgery significantly lowers the risk of serious liver complications among obese people with cirrhosis, or irreversible liver scarring and damage, due to metabolic…
FATTY LIVER DISEASE
NewsLanifibranor improves liver health in MASH with diabetes in trial
Daily treatment with the investigational oral therapy lanifibranor — used alone or in combination with the diabetes medication Jardiance (empagliflozin) — led to improvements…
FATTY LIVER DISEASE
NewsGut bacteria is involved in systems that help regulate fat in liver: Study
Biochemical crosstalk between the body’s own cells and microbes living in the intestines helps regulate the accumulation of fat in the liver, a new study…
Recent Posts
- One of my superpowers for MASH is defiance in the name of compliance
- Canada approves Livmarli oral tablets for Alagille itching
- New experimental therapy enters early human testing for hepatitis B
- Risk of PSC recurrence 4 times higher with living donor transplant: Study
- Early detection highlighted in this year’s Rare Liver Diseases Month